Weekly Recap

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

September 12, 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

September 05, 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

May 09, 2020

Neurology News Network for the week ending May 9, 2020.

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

May 02, 2020

Neurology News Network for the week ending May 2.

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

April 25, 2020

Neurology News Network for the week ending April 25, 2020.

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

April 18, 2020

Neurology News Network for the week ending April 18, 2020.

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

April 11, 2020

Neurology News Network for the week ending April 11, 2020.

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

April 04, 2020

Neurology News Network for the week ending April 4, 2020.

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

March 21, 2020

Neurology News Network for the week ending March 21, 2020.

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

March 14, 2020

Neurology News Network for the week ending March 14, 2020.